Company: BBVXF
Filing Date: 2025-03-21
Form Type: 6-K
Source: 0001193125-25-060013
Chunk: 5

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-03-21
Form: 6-K
Chunk 5
---
 (American Depositary Shares).                                                      |

| (v) | Execute all public and/or private documents, and to enter into as many acts, legal transactions, contracts,                                                                                                                                              
 declarations and operations that may be necessary or advisable to carry out each execution of the approved share capital reduction, as well as to attend to any formalities and obligations related to the capital reduction and each of its executions. |

| (vi) | Publish as many announcements as may be necessary or appropriate regarding the share capital reduction and each of its    
 executions, and carry out any actions required for the effective redemption of the shares referred to in this resolution. |

| (vii) | Set the terms and conditions of the reduction in any matters not provided in this resolution, as well as to carry out                
 any procedures and formalities required to obtain the consents and authorizations required for the effectiveness of this resolution. |

Three.-Nullify, for the unused part, the share capital reduction resolution adopted by the Annual General Shareholders’ Meeting held on 15 March 2024, under item three of the agenda.

| This                                                                                                                                                  
 English version is a translation of the original in Spanish for information purposes only. In case of discrepancy, the Spanish original will prevail. |

RESOLUTIONS UNDER AGENDA ITEM FOUR In relation to the first resolution to increase the share capital of Banco Bilbao Vizcaya Argentaria, S.A. (“BBVA”) via non-monetarycontributions (the “Capital Increase”) adopted by the Extraordinary General Shareholders’ Meeting held on July 5, 2024 (the “Extraordinary General Meeting”) under agenda item one (the “Resolution One”), renew and re-approveresolution two of delegation of powers related to the Capital Increase adopted by the Extraordinary General Meeting under the same agenda item, for its exercise within a one (1) year period from the date of adoption of this resolution, in the following terms: To empower the Board of Directors, in the broadest terms, authorizing it to sub-delegateon the Executive Committee (in turn, with sub-delegationpowers); on the Chair of the Board of Directors, the Chief Executive Officer and on any individual that the Board may expressly empower for such purposes, to fully or partially execute the previously approved Capital Increase, in one or several rounds, within the period of one (1) year since the adoption of this resolution, and establish its terms and conditions regarding any matters that may have not been stipulated by the Extraordinary General Meeting,